Default company panoramic image

Alphabiom Corporation

Devices and technologies for orthopedic, trauma and neuro surgeries. Biomaterial and tissue engineering for bone substitutes and healing

Company Summary

Devices, biomaterials, and mininally invasive technologies for trauma, orthopedics surgery and neurosurgery market. About 25/1000 people have an orthopedic surgery, more have trauma surgery.Trauma and aging population drives growth of the global orthopedics devices market. Spinal devices are the fastest growing segment with a CAGR of 9.3%. By regulation, customers are mainly hospitals and independent physicians and/or their delegates.


  • Default avatar
    Fidele Likibi
    Presdent, CEO

    Ph.D., M.A.Sc. in BME (spine devices, bone substitutes). Postgraduate specializations in artificial organs, biomaterials, biomechanics, biostatistics). 12 years of experience in biomedical research at both private and academic institutions including Sainte-Justine Hospital and Biorthex Inc. in Montreal, Clinic Cecil and Gambro corp. in Lausanne (Switzerland), and West Virginia University in Morgantown (USA).


  • Default avatar
    Taylor Leybow LLC

Previous Investors

  • Default avatar
    Dr. Aleksandra Laskowska Bruno (Italy)
    Default avatar
    Mr. Eldo Mabiala (Switzerland)